Neurotrophic B-Vitamins & Methylation • NIH Office of Dietary Supplements (DSLD)

Allergy Research Group Quatreactiv Folate

Active Constituents: Folate, 5-Methyltetrahydrofolate, L-Leucine

Mood Disorders (F32.2) Postconcussion syndrome (F07.81) Oppositional defiant disorder (ODD) (F91.3) Laxative abuse (F55.2)

Audited by the DotMD AI Specialist Council • NIH DSLD #233297 • 7 Linked .gov / PubMed Citations

Methodology & AI Transparency ⓘ

Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.

At a Glance • Plain-English Clinical Summary

Allergy Research Group Quatreactiv Folate Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

82%

Patient “Worth It” (10)

$22

Lowest Cash / Mo

1 What it does: Cataloged in the federal NIH DSLD registry under ID #233297, Allergy Research Group Quatreactiv Folate provides Folate, 5-Methyltetrahydrofolate, L-Leucine (from 925 mcg (6S)-5-methyltetrahydrofolic acid, glucosamine salt) in a capsule matrix.
2 Real-world patient consensus: Logged by 10 Zero-PHI community members with a 82% satisfaction rating (#233297).
3 Typical cash cost range: Typical monthly cost benchmark: ~$22.04 for daily Allergy Research Group Quatreactiv Folate maintenance.
4 Top reported side effects / signs: Primary co-medication note for Allergy Research Group Quatreactiv Folate: Methotrexate (Oncology / High-Dose).

Pharmacology & Clinical Trial Dosing

How Allergy Research Group Quatreactiv Folate Works & Standard Studied Dosages

Cataloged in the federal NIH DSLD registry under ID #233297, Allergy Research Group Quatreactiv Folate provides Folate, 5-Methyltetrahydrofolate, L-Leucine (from 925 mcg (6S)-5-methyltetrahydrofolic acid, glucosamine salt) in a capsule matrix. Designed for neurotrophic b-vitamins & methylation maintenance, it pairs label-verified composition with a 82% community rating.

Through capsule delivery of Folate, 5-Methyltetrahydrofolate, L-Leucine (from 925 mcg (6S)-5-methyltetrahydrofolic acid, glucosamine salt), Allergy Research Group Quatreactiv Folate modulates the rate-limiting cofactor for tryptophan hydroxylase across neurotrophic b-vitamins & methylation pathways.

Typical Human Study Regimens

Daily capsule intake of Allergy Research Group Quatreactiv Folate with food (Label #233297) Cycle or maintain Allergy Research Group Quatreactiv Folate (folate) under clinician guidance

View Official NIH Office of Dietary Supplements Fact Sheet ↗

Dr. Vance (AI PharmD Clinical Pharmacologist)

Allergy Research Group Quatreactiv Folate Prescription Drug Interactions & Side Effects

Run Multi-Drug Interaction Checker →

Methotrexate (Oncology / High-Dose) Major

Review methotrexate (oncology / high-dose) timing when initiating Allergy Research Group Quatreactiv Folate (DSLD #233297) to avoid absorption or pharmacodynamic overlap.

Reported Side Effects & Tolerability Notes

Occasional mild GI fullness if Allergy Research Group Quatreactiv Folate (capsule) is taken on an empty stomach Check NIH DSLD #233297 excipient list for Allergy Research Group capsule/binder sensitivities

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Allergy Research Group Quatreactiv Folate

3 of 3 Free Questions Remaining

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Allergy Research Group Quatreactiv Folate)

Browse All PubMed Translations →

Study & Plain-English Finding	Sample (N)	Rigor	Primary Source
Check Your Medicine Cabinet: WinCo Foods LLC Issues Allergy Alert on Undeclared Sesame in Hoagie Rolls October 22, 2026 - WinCo Foods of Boise, ID is recalling the following WinCo Foods Brand Hoagie Rolls due to undeclared sesame. FDA Drug Recalls • 2026-10-22 • FDA Recall	Multi-cohort	95/100	PMID FDA_RECALLS-3221894050 ↗
Check Your Medicine Cabinet: Pan Pepin Inc. Issues Allergy Alert of Para Bien Al Grano Due to Undeclared Sesame Pan Pepin Inc. of Bayamón, Puerto Rico is recalling certain lots of Para Bien Al Grano because the product contain sesame. FDA Drug Recalls • 2026-10-13 • FDA Recall	Multi-cohort	95/100	PMID FDA_RECALLS-2875230887 ↗
Can This Approach Help? Inside the Latest Research on Oral desensitization therapy for peanut allergy induces dynamic changes in Oral desensitization therapy with AR101 leads to decreased basophil sensitivity to peanut and reshapes peanut-reactive T effector cell responses supporting its potential as an immunomodulatory therapy. Allergy • 2022-08-15 • Phase III Randomized Trial	Multi-cohort	88/100	PMID 35266148 ↗
Can This Approach Help? Inside the Latest Research on Benefits and safety of epicutaneous immunotherapy in children with peanut allergy The results suggest that 12 months of treatment with VP250 was effective in desensitizing children with peanut allergy aged 1 to 3 years, with no difference in efficacy and a favorable safety profile, regardless of the... Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2025-08-15 • Phase III Randomized Trial	Multi-cohort	88/100	PMID 40204253 ↗

Allergy Research Group Quatreactiv Folate Patient Community Discussions & 15-Second Logs

Filter real-world Allergy Research Group Quatreactiv Folate experiences by age, biological sex, dosage, and duration.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Allergy Research Group Quatreactiv Folate community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Allergy Research Group Quatreactiv Folate.